Copper Rock Capital Partners LLC boosted its stake in shares of Halyard Health Inc (NYSE:HYH) by 3.6% during the fourth quarter, Holdings Channel reports. The fund owned 677,184 shares of the medical instruments supplier’s stock after acquiring an additional 23,469 shares during the period. Halyard Health makes up approximately 2.0% of Copper Rock Capital Partners LLC’s holdings, making the stock its 23rd biggest holding. Copper Rock Capital Partners LLC’s holdings in Halyard Health were worth $31,631,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of HYH. Schwab Charles Investment Management Inc. grew its holdings in Halyard Health by 3.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 797,993 shares of the medical instruments supplier’s stock worth $31,346,000 after acquiring an additional 27,421 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Halyard Health by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 885,238 shares of the medical instruments supplier’s stock worth $34,772,000 after acquiring an additional 3,596 shares during the last quarter. Legal & General Group Plc grew its holdings in Halyard Health by 9.8% during the 2nd quarter. Legal & General Group Plc now owns 71,313 shares of the medical instruments supplier’s stock worth $2,803,000 after acquiring an additional 6,392 shares during the last quarter. Victory Capital Management Inc. grew its holdings in Halyard Health by 17.7% during the 2nd quarter. Victory Capital Management Inc. now owns 4,732 shares of the medical instruments supplier’s stock worth $186,000 after acquiring an additional 711 shares during the last quarter. Finally, Principal Financial Group Inc. grew its holdings in Halyard Health by 15.9% during the 2nd quarter. Principal Financial Group Inc. now owns 223,961 shares of the medical instruments supplier’s stock worth $8,797,000 after acquiring an additional 30,793 shares during the last quarter. 89.71% of the stock is currently owned by hedge funds and other institutional investors.

Halyard Health Inc (NYSE:HYH) traded up $0.09 during trading on Monday, reaching $47.90. 127,900 shares of the company’s stock were exchanged, compared to its average volume of 189,180. The company has a current ratio of 2.13, a quick ratio of 1.19 and a debt-to-equity ratio of 0.49. Halyard Health Inc has a 52 week low of $35.24 and a 52 week high of $50.99. The firm has a market cap of $2,240.00, a P/E ratio of 40.25, a PEG ratio of 2.51 and a beta of 1.76.

Halyard Health (NYSE:HYH) last released its earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.13. Halyard Health had a net margin of 3.52% and a return on equity of 8.65%. The company had revenue of $401.40 million for the quarter, compared to the consensus estimate of $394.54 million. During the same period in the prior year, the company posted $0.48 EPS. The company’s revenue was up 1.0% compared to the same quarter last year. research analysts expect that Halyard Health Inc will post 2.08 earnings per share for the current fiscal year.

A number of brokerages have commented on HYH. Zacks Investment Research raised shares of Halyard Health from a “hold” rating to a “buy” rating and set a $53.00 price objective on the stock in a report on Thursday. ValuEngine upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. TheStreet upgraded shares of Halyard Health from a “c+” rating to a “b” rating in a research report on Monday, December 4th. Stifel Nicolaus restated a “buy” rating and set a $52.00 target price on shares of Halyard Health in a research report on Friday, November 3rd. Finally, KeyCorp restated a “hold” rating on shares of Halyard Health in a research report on Tuesday, October 17th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $49.00.

COPYRIGHT VIOLATION WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2018/01/09/halyard-health-inc-hyh-shares-bought-by-copper-rock-capital-partners-llc.html.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health Inc (NYSE:HYH).

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Stock Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related stocks with our FREE daily email newsletter.